During the past decade, MD Anderson Cancer Center Department of Lymphoma & Myeloma conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 2 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "MD Anderson Cancer Center Department of Lymphoma & Myeloma" #1 collaborator was "Fondazione Italiana Linfomi ONLUS" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "MD Anderson Cancer Center Department of Lymphoma & Myeloma" are "Diffuse Large B-Cell Lymphoma" (1 trials) and "Lymphoma, B-Cell" (1 trials). Many other conditions were trialed in "MD Anderson Cancer Center Department of Lymphoma & Myeloma" in a lesser frequency.

Most popular intervention types in "MD Anderson Cancer Center Department of Lymphoma & Myeloma" are "Drug" (2 trials). Other intervention types were less common.

The name of intervention was led by "Cyclophosphamide" (1 trials), "Doxorubicin" (1 trials), "Obinutuzumab" (1 trials), "Prednisone" (1 trials) and "Rituximab" (1 trials). Other intervention names were less common.

The vast majority of trials in "MD Anderson Cancer Center Department of Lymphoma & Myeloma" are 2 trials for "All" genders.

Currently, there are NaN active trials in "MD Anderson Cancer Center Department of Lymphoma & Myeloma". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 1 completed trials in MD Anderson Cancer Center Department of Lymphoma & Myeloma, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in MD Anderson Cancer Center Department of Lymphoma & Myeloma, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 1 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".